Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00126880
Status:
COMPLETED
Last Update Posted:
2011-06-23
First Post:
2005-08-03
Brief Title:
AVX754 a New Nucleoside Reverse Transcriptase Inhibitor NRTI to Treat Drug-resistant HIV
Sponsor:
Avexa
Organization:
Avexa
Organization Data
Organization:
Avexa
Class:
INDUSTRY
Study ID:
AVX-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Avexa
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Susan Cox
Old Organization:
Avexa